BioSpecifics Technologies
BSTC
#6769
Rank
C$0.89 B
Marketcap
C$121.33
Share price
0.15%
Change (1 day)
N/A
Change (1 year)

Revenue for BioSpecifics Technologies (BSTC)

Revenue in 0 (TTM): N/A

.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioSpecifics Technologies from to

Annual revenue

Year Revenue Change

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Abbott Laboratories
ABT
C$60.08 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$81.74 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$81.43 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
C$4.99 BN/A๐Ÿ‡ฎ๐Ÿ‡ช Ireland